[HTML][HTML] Long-term consequences of COVID-19: research needs

…, E Wirtheim, P Vetter, AC Kalil, J Bruchfeld… - The Lancet Infectious …, 2020 - thelancet.com
Weeks and months after the onset of acute COVID-19, people continue to suffer. Paul Garner,
a professor of epidemiology at Liverpool School of Tropical Medicine, UK, wrote on the …

Long-haul post–COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience

…, J Nilsson, B Olshansky, J Bruchfeld… - Case Reports, 2021 - jacc.org
Major clinical centers in Sweden have witnessed an inflow of patients with chronic symptoms
following initial outpatient care for coronavirus disease-2019 (COVID-19) infection, …

Tuberculosis and HIV coinfection

J Bruchfeld, M Correia-Neves… - Cold Spring …, 2015 - perspectivesinmedicine.cshlp.org
Tuberculosis (TB) and human immunodeficiency virus/acquired immunodeficiency syndrome
(HIV/AIDS) constitute the main burden of infectious disease in resource-limited countries. …

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries

…, SMB Gutierrez, J Bruchfeld… - European …, 2015 - Eur Respiratory Soc
Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …

Towards tuberculosis elimination: an action framework for low-incidence countries

…, V Bhatia, F Blasi, A Bloom, J Bruchfeld… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(<100 TB cases per million population) that are striving for TB elimination. The framework …

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study

…, R Amale, J Artsukevich, J Bruchfeld… - European …, 2017 - Eur Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-resistant
tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …

Risk assessment of tuberculosis in immunocompromised patients. A TBNET study

M Sester, F Van Leth, J Bruchfeld… - American journal of …, 2014 - atsjournals.org
Rationale: In the absence of active tuberculosis, a positive tuberculin skin test (TST) or
interferon-γ release assay (IGRA) result defines latent infection with Mycobacterium tuberculosis, …

Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis

IS Pradipta, LD Forsman, J Bruchfeld, E Hak… - Journal of Infection, 2018 - Elsevier
Objectives Since the risk of multidrug-resistant tuberculosis (MDR-TB) may depend on the
setting, we aimed to determine the associations of risk factors of MDR-TB across different …

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

…, LR Codecasa, A Aleksa, J Bruchfeld… - European …, 2019 - Eur Respiratory Soc
The World Health Organization (WHO) recommends that countries implement pharmacovigilance
and collect information on active drug safety monitoring (aDSM) and management of …

Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine

B Hamasur, J Bruchfeld, M Haile, A Pawlowski… - Journal of …, 2001 - Elsevier
There is an urgent need for improved tools for laboratory diagnosis of active tuberculosis (TB).
Here, we describe two methods, a catch-up ELISA and a dipstick test based on the …